JP2010538011A5 - - Google Patents

Download PDF

Info

Publication number
JP2010538011A5
JP2010538011A5 JP2010523140A JP2010523140A JP2010538011A5 JP 2010538011 A5 JP2010538011 A5 JP 2010538011A5 JP 2010523140 A JP2010523140 A JP 2010523140A JP 2010523140 A JP2010523140 A JP 2010523140A JP 2010538011 A5 JP2010538011 A5 JP 2010538011A5
Authority
JP
Japan
Prior art keywords
composition
composition according
composition suitable
terpinen
use comprises
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010523140A
Other languages
English (en)
Other versions
JP2010538011A (ja
Filing date
Publication date
Priority claimed from US11/846,961 external-priority patent/US8128968B2/en
Application filed filed Critical
Publication of JP2010538011A publication Critical patent/JP2010538011A/ja
Publication of JP2010538011A5 publication Critical patent/JP2010538011A5/ja
Pending legal-status Critical Current

Links

Claims (15)

  1. ニキビダニ属感染症又はニキビダニ属に誘発される眼瞼炎の治療における使用に適した組成物であって、
    該組成物がティートリーオイル中に見いだされる抗ニキビダニ属活性化合物を含むことを特徴とする組成物。
  2. 前記使用に適した組成物がテルピネン−4−オル、α−テルピネオル、テルピノレン、γ−テルピネン、1,8シネオール、α−テルピネン、リモネン又はティートリーオイルを含むことを特徴とする請求項1記載の組成物。
  3. 前記使用に適した組成物が皮膚科的に許容される基剤を含むことを特徴とする請求項1又は2に記載の組成物。
  4. 前記使用に適した組成物が眼科的に許容される基剤を含むことを特徴とする請求項1又は2に記載の組成物。
  5. 前記使用に適した組成物が目を刺激する薬剤を略含まないことを特徴とする請求項4に記載の組成物。
  6. 前記使用に適した組成物がテルピネン−4−オルを含むことを特徴とする請求項3乃至5いずれかに記載の組成物。
  7. 前記使用に適した組成物が5%から100%w/wのテルピネン−4−オルを含むことを特徴とする請求項6記載の組成物。
  8. 前記使用に適した組成物が10%から100%w/wのテルピネン−4−オルを含むことを特徴とする請求項6記載の組成物。
  9. 前記使用に適した組成物が5%から50%のテルピネン−4−オルを含むことを特徴とする請求項6記載の組成物。
  10. 前記使用に適した組成物が5%から15%w/wのテルピネン−4−オル、例えば10%を含むことを特徴とする請求項6記載の組成物。
  11. 前記使用に適した組成物が0.2%から20%w/wのティートリーオイル、例えば3.0%から15%、4%から10%、又は5%w/wのティートリーオイルを含むことを特徴とする請求項1乃至5いずれかに記載の組成物。
  12. 前記使用に適した組成物が軟膏の形態であることを特徴とする請求項1乃至11いずれかに記載の組成物。
  13. ニキビダニ属感染症又はニキビダニ属に誘発される眼瞼炎の治療における眼科的な使用に適した組成物であって、
    該組成物がティートリーオイル中に見いだされる抗ニキビダニ属活性化合物を含むことを特徴とする組成物。
  14. 前記組成物が請求項1乃至12のいずれかに説明されるニキビダニ属薬剤を含むことを特徴とする請求項13に記載の化合物。
  15. 前記組成物が目を刺激し或いは目を害する薬剤を略含まないとともに、テルピネン−4−オルを、例えば、5%から100%、10%から100%、5%から50%、5%から15%又は10%w/wを含むことを特徴とする請求項13に記載の組成物。
JP2010523140A 2007-08-29 2008-08-28 ニキビダニ属感染症の治療のための組成物及び方法 Pending JP2010538011A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/846,961 US8128968B2 (en) 2007-08-29 2007-08-29 Compositions and methods for treating Demodex infestations
PCT/US2008/074674 WO2009032773A2 (en) 2007-08-29 2008-08-28 Compositions and methods for treating demodex infestations

Publications (2)

Publication Number Publication Date
JP2010538011A JP2010538011A (ja) 2010-12-09
JP2010538011A5 true JP2010538011A5 (ja) 2011-01-27

Family

ID=40407911

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010523140A Pending JP2010538011A (ja) 2007-08-29 2008-08-28 ニキビダニ属感染症の治療のための組成物及び方法

Country Status (8)

Country Link
US (3) US8128968B2 (ja)
EP (1) EP2192913A4 (ja)
JP (1) JP2010538011A (ja)
KR (1) KR101176380B1 (ja)
CN (2) CN101795700A (ja)
CA (1) CA2694767C (ja)
HK (1) HK1204277A1 (ja)
WO (1) WO2009032773A2 (ja)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006119174A1 (en) 2005-04-30 2006-11-09 Ocular Surface Center, P.A. Method for treating ocular demodex
US8128968B2 (en) * 2007-08-29 2012-03-06 Tissuetech, Inc. Compositions and methods for treating Demodex infestations
US20090317503A1 (en) * 2008-06-20 2009-12-24 Ocusoft, Inc. Eyelid Preparation and Method of Use
US8895080B2 (en) 2008-06-20 2014-11-25 Ocusoft, Inc. Compositions and kits for ocular treatment
KR101022550B1 (ko) 2009-06-02 2011-03-16 고인순 모낭충 제거 효과를 갖는 크렌징 조성물
KR101792778B1 (ko) 2010-10-26 2017-11-01 삼성전자주식회사 비휘발성 메모리 장치 및 그 형성 방법
WO2012092320A2 (en) 2010-12-29 2012-07-05 Nichamin Louis D Eye treatment
IL217807A (en) 2012-01-29 2017-01-31 Tel-Ari Ruben Local medical preparations based on tto
CN103055158A (zh) * 2012-12-27 2013-04-24 王荣华 一种治疗鳞屑性睑缘炎的中药组合物
US11446241B2 (en) * 2013-07-29 2022-09-20 Attillaps Holdings Inc. Treatment of ophthalmological conditions with acetylcholinesterase inhibitors
WO2019126541A1 (en) * 2017-12-20 2019-06-27 Attillaps Holdings Treatment of ophthalmological conditions with acetylcholinesterase inhibitors
DE102013223795A1 (de) 2013-11-21 2014-04-10 Henkel Ag & Co. Kgaa Verwendung kosmetischer Zusammensetzungen für die Inaktivierung und/oder Eliminierung von Hautmilben
DE102013223790A1 (de) 2013-11-21 2015-05-21 Henkel Ag & Co. Kgaa Verwendung kosmetischer Zusammensetzungen für die Inaktivierung und/oder Eliminierung von Hautmilben
DE102013223792A1 (de) 2013-11-21 2015-05-21 Henkel Ag & Co. Kgaa Verwendung kosmetischer Zusammensetzungen für die Inaktivierung und/oder Eliminierung von Hautmilben
DE102013223789A1 (de) 2013-11-21 2014-04-10 Henkel Ag & Co. Kgaa Verwendung kosmetischer Zusammensetzungen für die Inaktivierung und/oder Eliminierung von Hautmilben
DE102013223793A1 (de) 2013-11-21 2014-04-10 Henkel Ag & Co. Kgaa Verwendung kosmetischer Zusammensetzungen für die Inaktivierung und/oder Eliminierung von Hautmilben
CA2955975A1 (en) 2014-05-28 2015-12-03 Lunovus, Llc Ocular eyelid scrub composition for the treatment of demodex blepharitis
CA2952838C (en) * 2014-06-19 2023-09-05 Attillaps Holdings Acetylcholinesterase inhibitors for treatment of dermatological conditions
RU2558074C1 (ru) * 2014-07-08 2015-07-27 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский институт ветеринарной энтомологии и арахнологии" (ФГБНУ ВНИИВЭА) Способ лечения демодекоза крупного рогатого скота
WO2016010984A2 (en) * 2014-07-14 2016-01-21 Tissue Tech, Inc. Compositions and methods for treating rosacea
US9463201B2 (en) 2014-10-19 2016-10-11 M.G. Therapeutics Ltd Compositions and methods for the treatment of meibomian gland dysfunction
CN108472312A (zh) 2015-09-28 2018-08-31 阿祖拉眼科有限公司 用于增加睑板腺脂质分泌物的含硫醇及二硫化物的药剂
EP3442519A4 (en) 2016-04-14 2019-12-04 Azura Opthalmics Ltd. SELENIUM DISULFIDE COMPOSITIONS FOR USE IN THE TREATMENT OF MEIBOMIUS GLAND DYSFUNCTION
IT201600096125A1 (it) 2016-09-26 2018-03-26 Ntc Srl Complesso e composizioni per il trattamento di affezioni oculari e cutanee
RU2652073C1 (ru) * 2017-04-28 2018-04-24 Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский Томский государственный университет" (ТГУ, НИ ТГУ) Способ лечения блефарита
EP3415142B1 (en) 2017-06-12 2020-12-09 Novax Pharma S.A.M. Composition for the treatment of blepharitis containing terpinen-4-ol
WO2019057899A1 (en) 2017-09-22 2019-03-28 Lipid Systems Sp. Z.O.O. AQUEOUS COMPOSITION COMPRISING AT LEAST ONE PHOSHOLIPID AND AT LEAST ONE TERPENE WITH ACIDICITY ACTIVITY AGAINST DEMODEX
JP2021506971A (ja) 2017-12-15 2021-02-22 ターサス ファーマシューティカルズ, インコーポレイテッド イソキサゾリン系寄生虫駆除剤及び眼瞼炎を治療する方法
AU2019309520A1 (en) * 2018-07-27 2021-03-11 Aperta Biosciences, Llc Spinosyn formulations for treatment of demodex-induced ocular and facial conditions
CN109077947A (zh) * 2018-08-30 2018-12-25 湖北舒邦药业有限公司 一种医用眼科冷敷敷料及其制备方法
BR112021006821A2 (pt) * 2018-10-12 2021-07-13 Hovione Scientia Limited método de tratamento de inflamação e patologias oftálmicas, dispersão sólida, formulação farmacêutica, método de matar ácaros e kit
US20210052490A1 (en) * 2019-08-20 2021-02-25 Vishwanath Padmanabhan Compositions and methods for the treatment of anterior blepharitis and posterior blepharitis
JP2023510499A (ja) 2020-01-10 2023-03-14 アズーラ オフサルミックス エルティーディー. 組成物および過敏症のための指示
CN111297948B (zh) * 2020-02-13 2021-12-14 周立光 一种治疗蠕形螨睑缘炎的眼贴和制备方法
CN114931646A (zh) * 2020-03-20 2022-08-23 山东省眼科医院 一种治疗螨虫性睑缘炎的茶树油制剂及其制备方法
US20220323472A1 (en) * 2021-03-30 2022-10-13 Frank Anthony SPALLITTA Anti-parasitic compounds for the treatment and prevention of viral diseases

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7607496L (sv) * 1976-07-01 1978-01-02 Astra Laekemedel Ab Sett for bekempning av virusinfektioner
AU559001B2 (en) * 1980-09-05 1987-02-19 Sedgewick, S.E. Skin cream containing tea tree oil
US4745100A (en) * 1985-05-14 1988-05-17 Eye Research Institute Of Retina Foundation Stimulation of tear secretion
US5208257A (en) * 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
CA1296329C (en) * 1986-06-06 1992-02-25 Derek R. Sutherland Macrolide compounds
US5052558A (en) 1987-12-23 1991-10-01 Entravision, Inc. Packaged pharmaceutical product
US5033252A (en) 1987-12-23 1991-07-23 Entravision, Inc. Method of packaging and sterilizing a pharmaceutical product
JPH04198131A (ja) * 1990-11-28 1992-07-17 Takeda Chem Ind Ltd 創傷治癒促進剤およびそれを含有する外用組成物
US5323907A (en) 1992-06-23 1994-06-28 Multi-Comp, Inc. Child resistant package assembly for dispensing pharmaceutical medications
US5444043A (en) * 1994-02-18 1995-08-22 The Regents Of The University Of California Cyclic heptapeptide anti-inflammatory agent
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
DE19511429A1 (de) * 1995-03-29 1996-10-02 Gerhard Linnhoff Pflegemittel für Haustiere und seine Anwendungen
US6022529A (en) * 1997-08-06 2000-02-08 California Institute Of Technology Photoresponsive sunscreen compositions
US6197305B1 (en) * 1998-01-05 2001-03-06 Farmo-Nat Ltd. Anti-fungal compositions with prolonged activity
DE19824681A1 (de) 1998-06-03 1999-12-09 Grewe Helmut F Milben tötendes Reinigungsmittel für Körper und Haare
GB2370989A (en) * 2001-01-16 2002-07-17 Btg Int Ltd Piperine analogues for the treatment of skin conditions
US20010051184A1 (en) * 1999-05-20 2001-12-13 Madalene C.Y. Heng Method for using soluble curcumin to inhibit phosphorylase kinase in inflammatory diseases
US20040235742A1 (en) 1999-08-10 2004-11-25 Santen Pharmaceutical Co., Ltd. Water channel opener compositions and medicinal compositions for ophthalmic use
PT1206942E (pt) 1999-08-10 2007-01-31 Santen Pharmaceutical Co Ltd Composições para abertura de canal de água e composições medicinais para utilização oftálmica
US6414036B1 (en) * 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
US6541042B1 (en) * 1999-10-27 2003-04-01 Bogar Ag Therapeutically effective combination
GB2362574B (en) * 2001-01-12 2002-04-24 Angus Erskine Stuart A formulation for the destruction of the eggs of chicken mites (Dermanyssus Gallinae)
US7121666B2 (en) 2001-04-25 2006-10-17 Tseng Scheffer C G Apparatus and method for the kinetic analysis of tear stability
US20030040504A1 (en) * 2001-05-09 2003-02-27 Gans Eugene H. Ectoparasiticidal compositions and methods of their use
IL158509A (en) * 2003-10-20 2010-11-30 Biomor Israel Ltd Non-phytotoxic biocide composition containing tea tree oil and method for production thereof
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20040197364A1 (en) * 2003-01-24 2004-10-07 Brown Paul R. Topical insect repellent
US7541155B2 (en) 2003-04-24 2009-06-02 Tyratech, Inc. Methods of screening compositions for potential insect control activity
US20050220742A1 (en) * 2004-03-31 2005-10-06 Breen Ed V Compositions and methods for maintaining eyelid hygiene
US20060068044A1 (en) * 2004-09-30 2006-03-30 Max Reynolds Antimicrobial compositions and applications therefore
US20060147408A1 (en) * 2005-01-06 2006-07-06 Vision Endurance Resource, Inc. Skin cleansing and sloughing solution
US20060188492A1 (en) 2005-01-13 2006-08-24 Chronorx Llc, An Alaska Limited Liability Company Topical management of ocular and periocular conditions
EP1883401B1 (en) * 2005-01-20 2015-11-11 Kayban Pty Ltd. Anti-microbial agent
WO2006119174A1 (en) 2005-04-30 2006-11-09 Ocular Surface Center, P.A. Method for treating ocular demodex
US7875620B2 (en) * 2005-06-30 2011-01-25 Piper Medical, Inc. Methods of treating microbial infections
JPWO2007145344A1 (ja) 2006-06-16 2009-11-12 ロート製薬株式会社 テルペノイドを含有するソフトコンタクトレンズ用眼科組成物
US8202853B2 (en) * 2006-11-03 2012-06-19 Ocusoft, Inc. Convenience kit for eyelid treatment
US8128968B2 (en) 2007-08-29 2012-03-06 Tissuetech, Inc. Compositions and methods for treating Demodex infestations

Similar Documents

Publication Publication Date Title
JP2010538011A5 (ja)
WO2015021382A3 (en) Topical compositions and methods of using the same
CA2894892A1 (en) Boronic acid derivatives and therapeutic uses thereof
WO2008116135A3 (en) Topical formulations having enhanced bioavailability
HRP20192266T1 (hr) Kompozicije i postupci za nekirurško liječenje ptoze
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
WO2009109618A3 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1
CA2894891A1 (en) Boronic acid derivatives and therapeutic uses thereof
WO2009115557A3 (en) Fungicide hydroximoyl-tetrazole derivatives
WO2009090237A3 (en) Fungicide hydroximoyl-tetrazole derivatives
NZ629045A (en) Topical compositions comprising fipronil and permethrin and methods of use
WO2009109616A3 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxrl and p40
EA201071166A1 (ru) Контролируемое высвобождение активных агентов из олеосом
WO2009109654A8 (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1
BR112014028069A2 (pt) composição farmacêutica oftálmica, processo para a preparação de uma composição farmacêutica oftálmica, uso de uma composição farmacêutica oftálmica, e, método para a prevenção ou tratamento de uma infecção fúngica
WO2013087548A3 (en) Loundry compositions
WO2014107730A3 (en) Use of fatty acid niacin conjugates for treating diseases
WO2012053009A3 (en) Pharmaceutical compositions comprising nano size droplets of skin whitening agents
WO2011080254A3 (en) Fungicide hydroximoyl-heterocycles derivatives
WO2015051045A3 (en) 3'END CAPS FOR RNAi AGENTS FOR USE IN RNA INTERFERENCE
WO2014064652A3 (en) Stable pharmaceutical composition of peginterferon alpha-2b
BR112014007177A2 (pt) agente antifúngico
JP2015504860A5 (ja)
EP4364810A3 (en) Topical formulations and uses thereof
WO2012077968A3 (en) Complex formulation comprising lercanidipine hydrochloride and valsartan and method for the preparation thereof